<DOC>
	<DOCNO>NCT00316563</DOCNO>
	<brief_summary>To investigate delta-9-tetrahydrocannabinol 's ( THC ) ability increase food intake improve food enjoyment advance cancer patient taste and/or smell ( chemosensory ) abnormality .</brief_summary>
	<brief_title>Orexigenic Therapy With Delta-9-tetrahydrocannabinol Advanced Cancer Patients With Chemosensory Abnormalities - Pilot Study</brief_title>
	<detailed_description>Appetite stimulant common treatment cancer-induced anorexia . However , 30 % advanced cancer patient respond benefit appetite stimulant , may due part sensory abnormality , person experience food aversion due taste smell change may unable respond agent . Of appetite stimulant available use clinical practice Marinol , THC , potential increase food intake improve appetite well amplify taste food brain 's reward pathway . A 22-day , double blind , randomize , placebo-controlled trial conduct . Participants start 2.5mg THC placebo daily first 3 day increase 2.5mg THC placebo twice daily lunch supper . Participant 's complete follow survey tool pre post-treatment : Taste Smell Survey assess severity change chemosensory complaint score ; 3-day dietary record determine change caloric intake shift food preference macronutrient analysis ; 24-hour urine collection validate 3-day dietary record ; Satiety Labelled Intensity Magnitude scale subjective appetite rating ; Food Preference Checklist assess objective shift macronutrient flavor preference ; Functional Assessment Anorexia/Cachexia Therapy questionnaire ass participant 's QOL ; interview determine cause effect chemosensory alteration ; Edmonton Symptom Assessment Scale ass nausea ; Side Effect Survey document tolerability drug ( post-treatment ) . Participants complete survey tool aid researcher . All tool short easy complete , minimizes patient burden .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Taste Disorders</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<criteria>advanced cancer patient ( define locally recurrent metastatic ) 18 year old decrease food intake least 2 week ( report physician subject ) able complete questionnaire English able provide inform consent life expectancy great 2 month ( determined physician ) chemosensory complaint score &gt; 1 receive enteral parenteral feeding allergy sensitivity THC and/or sesame seed oil history substance abuse psychotic episode mechanical obstruction alimentary tract , mouth nose receive chemotherapy last 2 week receive radiation therapy head/neck area brain tumor nausea score great 5 ESAS history tachyarrhythmias , angina pectoris hypertension current diagnosis liver impairment use marijuana within 30 day prior start trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>cannabinoids</keyword>
	<keyword>taste disorder</keyword>
	<keyword>olfaction disorder</keyword>
	<keyword>cancer</keyword>
	<keyword>palliative medicine</keyword>
	<keyword>caloric intake</keyword>
	<keyword>appetite</keyword>
	<keyword>reward</keyword>
	<keyword>tetrahydrocannabinol/therapeutic use</keyword>
	<keyword>anorexia/drug therapy</keyword>
	<keyword>quality life</keyword>
	<keyword>chemosensory changes/drug therapy</keyword>
</DOC>